Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

CureSearch for Children's Cancer has awarded a $20,000 grant to Beaumont Children's Hospital to help fund therapeutic clinical trials.

13 May 2014

Amrubicin promise for etoposide-naïve SCLC patients

Patients with chemotherapy-refractory small-cell lung cancer may benefit from treatment with the topoisomerase II inhibitor amrubicin, research from Japan suggests.

12 May 2014

Foundation Medicine obtains CE mark for FoundationOne

Foundation Medicine, Inc. today announced that it has obtained a CE mark for FoundationOne®. The CE mark allows FoundationOne to be placed on the market in the European Economic Area.

12 May 2014

Verastem announces expansion of ongoing COMMAND study in Japan

Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study to include clinical trial sites in Japan.

12 May 2014

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

North Shore Hematology Oncology Associates and Caris Life Sciences today announced a collaboration to establish a personalized cancer care program for patients in the greater Long Island area.

12 May 2014

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

12 May 2014

Flatiron Health agrees to acquire Altos Solutions

Altos Solutions, creators of OncoEMR, the first web-based oncology-specific electronic medical record, today announced an agreement to be acquired by Flatiron Health.

9 May 2014

Experimental antibody temporarily halts progression of neuroblastoma in children

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital.

9 May 2014

Comer Children's Hospital offers high-dose radiation therapy for relapsed neuroblastoma

The University of Chicago Medicine Comer Children's Hospital has become the first in Illinois to offer pioneering, targeted, high-dose, intravenous radiation therapy for relapsed neuroblastoma and other difficult-to-treat cancers.

9 May 2014

Johns Hopkins cancer center gets $10M gift for breast cancer-related programs

Officials at the Johns Hopkins Kimmel Cancer Center today announced receipt of a $10 million gift from Under Armour Inc. to fund breast cancer and breast health support programs and a women’s wellness center.

9 May 2014

Wake Forest Baptist Medical Center finds novel treatment to keep lung cancer at bay

An old idea of retreating lung tumors with radiation is new again, especially with the technological advances seen in radiation oncology over the last decade.

9 May 2014

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

Clovis Oncology, Inc. reported financial results for its first quarter ended March 31, 2014, and provided an update on the Company's clinical development programs for the rest of 2014.

9 May 2014

BTMed, SCCA expand early lung cancer detection program for high risk construction workers

Today, the Building Trades National Medical Screening Program (BTMed) and Seattle Cancer Care Alliance (SCCA) expanded their early lung cancer detection program (ELCD) for high risk construction workers in Western Washington.

9 May 2014

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.

9 May 2014

ImaginAb announces completion of $21M Series B financing

ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular imaging, announced today the completion of a $21M Series B financing of the company, led by Mérieux Développement and syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.

9 May 2014

NeoGenomics selects Aurora as primary partner for molecular testing

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has been selected by Aurora Diagnostics to be its primary partner for molecular testing at each of Aurora's 19 specialized anatomic pathology laboratories in the United States.

8 May 2014

MRI-guided focused ultrasound to treat pain from bone metastases

InSightec Ltd, the leader in magnetic resonance imaging guided Focused Ultrasound therapy (MRgFUS), announced that the results of its ExAblate® Phase III clinical trial for treating painful bone metastases have been published online in the JNCI, Journal of National Cancer Institute.

8 May 2014

Oncology News and Research

Further Reading

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

Amrubicin promise for etoposide-naïve SCLC patients

Foundation Medicine obtains CE mark for FoundationOne

Verastem announces expansion of ongoing COMMAND study in Japan

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Flatiron Health agrees to acquire Altos Solutions

Experimental antibody temporarily halts progression of neuroblastoma in children

Comer Children's Hospital offers high-dose radiation therapy for relapsed neuroblastoma

Johns Hopkins cancer center gets $10M gift for breast cancer-related programs

Wake Forest Baptist Medical Center finds novel treatment to keep lung cancer at bay

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

BTMed, SCCA expand early lung cancer detection program for high risk construction workers

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

ImaginAb announces completion of $21M Series B financing

NeoGenomics selects Aurora as primary partner for molecular testing

MRI-guided focused ultrasound to treat pain from bone metastases

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

First international molecular screening program at IMPAKT for metastatic breast cancer

Children's Hospital Los Angeles receives $3M from Simms/Mann Family Foundation

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News